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Abstract—The interactions of the antifouling compound Sea-Ninet with rat liver mitochondria have been studied. The results
indicate that low doses of this compound inhibit adenosine 59-triphosphate (ATP) synthesis. Further investigations indicate that
ATP synthesis inhibition should be due to an interaction of Sea-Nine with the succinic dehydrogenase in the mitochondrial respiratory
chain.
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INTRODUCTION
The chemical compound Sea-Ninet (4,5-dichloro-2-n-oct-
yl-3[2H] isothiazone [SN]), together with other organic com-
pounds, was tested for use as an antifouling compound to
replace tin compounds. Although tin compounds are efficient
as antifouling agents, it became necessary to replace them with
organic compounds because they are very toxic and persist for
a long time in the environment. For this reason, the use of
organotin compounds in antifouling paints has been restricted
in many countries: Regulation 782/2003 of the European Par-
liament and Council of April 14, 2003 prohibits tributyltin
(TBT)-containing paints to be applied to any vessel, as of July
1, 2003, and enforces the complete removal of TBT from ship
hulls as of January 1, 2008.
The Sea-Nine compound is effective as an antifouling agent
[1,2], but it also is degraded rapidly by microorganisms in the
environment [3]. This property reduces the toxicity of SN.
However, it has not been assayed quantitatively in animals
belonging to a higher order, not only because the measurements
require long durations, substantial laboratory space, costs, and
so on, but also because the acute effects (short-term effects)
are of the same order of magnitude as the decay time con-
cerning SN [3].
Studies of the in vitro toxicity of this compound have been
performed on fish cells [4] and the viability of the cells has
been evaluated using the Alamar Blue dye. It has been dem-
onstrated that, in many cases, the preferential target of the
toxic compounds responsible for acute toxicity are mitochon-
dria [5–8]. Therefore, in this study, we used the mitochondria
(from rat liver) to study the molecular effects of SN, because
the behavior and the molecular structure of mitochondria is
similar in all living species. The results suggest that the pref-
erential target in mitochondria is the respiratory chain. This
behavior could explain both the toxicity and the action of SN
as an antifouling compound.
* To whom correspondence may be addressed
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MATERIALS AND METHODS
The mitochondria were prepared from the livers of fasted
albino Wistar rats, weighing about 300 g [9]. The mitochon-
drial protein was determined using the procedure of Lowry et
al. [10].
The mitochondrial oxygen consumption was measured us-
ing a Clark oxygen electrode (Yellow Springs Instruments,
Yellow Springs, OH, USA) fitted in a thermostat-controlled,
closed chamber equipped with magnetic stirring. The reaction
medium (2 ml) was kept thermostated at 258C during all the
experiments (standard in vitro conditions).
The following reducing substrates were used: Succinate (2
mM), glutamate/malate (2 mM), and ascorbate ([1 mM]/[400
mM]) N,N,N9,N9-tetramethyl-p-phenylenediamine (TMPD).
The rate of Ca21 influx/efflux was monitored by means of
a selective Ca21 electrode (Beckman Coulter, Fullerton, CA,
USA) in a glass vessel with a magnetic stirring at room tem-
perature. The recording apparatus was a Radiometer pH-meter
connected to a Texas recorder (Texas Instruments, Dallas, TX,
USA).
Following the absorbance decrease, the swelling experi-
ments were performed at 540 nm, in a Jenway 6400 (Felsted,
Essex, UK) spectrophotometer, equipped with a stirring ap-
paratus. After the addition of the mitochondria to the resus-
pending medium (2.5 ml), the instrument was adjusted to zero
absorbance.
The ATP synthesis/hydrolysis experiments were performed
in a low buffered medium, using a pH electrode, connected
to a Radiometer PHM (pH-meter) 84 (Radiometer, Copenha-
gen, Denmark) in order to monitor the pH changes that ac-
company the reaction:
1ADP 1 Pi 1 H ↔ ATP
under stirring conditions at room temperature (ADP 5 aden-
osine 59-diphosphate).
All the reagents were of an analytical grade. The reagents
carbonylcyanide-p-trifluoromethoxyphenyl hydrazone, Ruthe-
nium Red, sodium glutamate, sodium malate, Oligomycin, and
TMPD were obtained from Sigma (Milan, Italy). Sea Ninet
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Fig. 1. Adenosine 59-triphosphate (ATP) synthesis inhibition by Sea-
Ninet ([SN], Rohm & Haas, Philadelphia, PA, USA) in rat liver
mitochondria. The ATP synthesis is followed by means of a pH elec-
trode, in a low-buffered medium. Medium composition: 0.25 M su-
crose, 100 mM Hepes pH 7.4, 200 mM ethylene glycol-bis(2-ami-
noethylether)-N,N,N9,N9-tetraacetic acid, 2 mM MgCl2, 2 mM ADP,
0.5 mM K2HPO4, and 2 mM succinate. The final concentration of
mitochondria: 0.5 mg/ml. The addition of mmol amounts of SN, sim-
ilar to a typical experiment in Figure 1a, induces a decrease in the
acidification rate, consequent to the ATP synthesis inhibition (Fig.
1a). It should be noted that, after the complete inhibition of the ATP
synthesis, a further addition of SN causes an alkalinization in the
medium, thus suggesting (see experiments of Fig. 2) that SN does
not inhibit the enzyme ATPase (the enzyme that catalyses the ATP
synthesis). The graph (b) reports the ATP synthesis inhibition as a
function of the SN concentration. The value of 100% corresponds to
the rate of ATP synthesis in the absence of SN.
Fig. 2. In vitro adenosine 59-triphosphate (ATP) hydrolysis in rat liver
mitochondria after addition of Sea-Ninet ([SN], Rohm & Haas, Phil-
adelphia, PA, USA) and Oligomycin (specific mitochondrial ATPase
inhibitor [the enzyme that catalyses the ATP synthesis]). The medium
contained: 0.25 M sucrose, 100 mM Hepes pH 7.4, 200 mM ethylene
glycol-bis(2-aminoethylether)-N,N,N9,N9-tetraacetic acid, and 2 mM
MgCl2. The mitochondria were added to the medium (4 ml) and the
final concentration was 0.5 mg/ml. The addition of 2 mM ATP causes
alkalinization with a rate that is not modified by the addition of SN
up to 80 mM. The addition of 2 g Oligomycin, the ATPase inhibitor,
induces a complete inhibition of the alkalinization rate.
(4,5-dichloro-2-n-octyl-3-isothiazone) was supplied by Rohm
& Haas (Philadelphia, PA, USA).
RESULTS AND DISCUSSION
In the mitochondria, substrates arising from the Krebs cycle
are oxidized by molecular oxygen, and ATP is produced. The
oxidation occurs by means of a sequence of cytochromes: The
mitochondrial respiratory chain (RC). Coupled to the electron
flow in the RC, a proton extrusion occurs and, because the
mitochondrial membrane is not permeant to the protons, their
extrusion causes a DpH (alkaline inside) and a potential differ-
ence, DC (negative inside). The sum of the DpH and DC was
named by Mitchell [11] as the proton motive force (PMF)
PMF 5 DpH 1 Dc
This is the high-energy intermediate that stores the free energy
arising from the substrates oxidation, which subsequently is
transferred to the ADP to form ATP.
In order to verify if the mitochondria are a target for the
SN, the rate of ATP synthesis in the presence of the SN was
measured. Figure 1a shows a typical experiment of the ATP
synthesis rate and its inhibition by the SN. The graph in Figure
1b reports the rate of ATP synthesis with increasing amounts
of SN and shows that the SN actually inhibits the ATP syn-
thesis at low doses.
Taking into account the mechanism that drives ATP syn-
thesis [11] (see above), the inhibition of the ATP is due to one
of the following four causes: Inhibition of the ATPase, un-
coupling effect, opening of the permeability transition pore,
or inhibition of the respiratory chain.
Inhibition of the ATPase
The ATPase is the enzyme that catalyses and drives the
conversion of the ADP into ATP. The inhibition of this enzyme
gives rise to a corresponding inhibition of the ATP synthesis.
Because ATP hydrolysis, which is catalyzed by the same en-
zyme (the ATPase), induces acidification of the medium, the
measurement of the ATPase inhibition was followed using a
pH-meter, in a low-buffered medium. Figure 2 shows an ex-
ample of this measurement. As a means of comparison, the
response of the system to the presence of the potent ATPase
inhibitor, Oligomycin, is shown. The addition of amounts of
SN, in doses up to more than 100 mM, does not change the
rate of ATP hydrolysis. Consequently, we concluded that SN
is not an ATPase inhibitor.
Uncoupling effect
Uncoupling compounds are chemical compounds that per-
meate the mitochondrial membrane to the protons. Because
the PMF results from the impermeability to the protons, the
uncouplers cause the inhibition of the ATP synthesis.
The uncouplers are weak acids (or weak bases). For ex-
ample, 2,4-dinitrophenol, a weak acid (pka 5 4.3, where ka is
the acidity constant and p is the 2log), is an uncoupler because
it enters as an undissociated compound and tends to accu-
mulate in the matrix, because the driving force is the alkaline-
inside pH. Once inside, the phenolate ion is extruded by the
negative-inside potential. This extrusion gives rise to a cyclic
mechanism and the whole balance is the entry of a proton at
any cycle.
This mechanism cannot be proposed as regards SN because
SN is not a weak acid (or a weak base). However, it cannot
be excluded that SN acts by means of a detergent-like effect
[12], causing an enhancement of the permeability to all ions,
the protons enclosed. In order to ascertain this possibility, we
measured the rate of Ca21 efflux, which previously had ac-
cumulated in the energized mitochondria (see Materials and
Methods section). Since following the accumulation of the
Ca21, the Ca21 carrier has been inhibited using Ruthenium Red
[9,13]; the rate of Ca21 efflux from the matrix to the resus-
pending medium is a measure of the membrane leak, or de-
tergent effect induced by the SN. Figure 3 shows a typical
experiment concerning Ca21 release after its accumulation in
the matrix, by means of ATP. The addition of Ruthenium Red
induces only a negligible Ca21 release, and the successive ad-
dition of SN induces a significant Ca21 release. Figure 3b
reports the rate of Ca21 release at different SN concentrations.
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Fig. 3. Sea-Ninet([SN], Rohm & Haas, Philadelphia, PA, USA) in-
duces a Ca21 release in energized rat liver mitochondria (detergent
effect). The mitochondria (0.5 mg/ml) were resuspended in a medium
containing: 0.25 M sucrose, 10 mM Hepes-Mops pH 7.4, 2 g cyclo-
sporine, 30 mM CaCl2, and 10 mM sodium acetate. The addition of
2 mM adenosine 59-triphosphate (ATP) induces Ca21 uptake up to a
steady state, which is measured by means of a selective Ca21 electrode.
In this situation, the addition of 1 mM Ruthenium Red (RR) inhibits
the Ca21 carrier and, subsequently, the addition of SN induces a Ca21
release due to a detergent (or membrane leak mechanism) (a). The
graph (b) reports the initial rate of the Ca21 efflux, induced by the
SN, which is the slope in the dotted line (a). It should be noted that
the effect of the SN is relevant only when the concentration of SN
is above 20 n mol/mg (10 mM).
Fig. 4. Swelling of rat liver mitochondria induced by Sea-Ninet ([SN],
Rohm & Haas, Philadelphia, PA, USA). The swelling of the mito-
chondria was monitored following the absorbance quenching at 540
nm. The mitochondria (0.5 mg/ml) were resuspended in a medium
containing: 0.25 M sucrose, 10 mM Hepes-Mops, pH 7.4, 200 mM
ethylene glycol-bis(2-aminoethylether)-N,N,N9,N9-tetraacetic acid,
and 2 mM MgCl2. The addition of SN induces swelling. (a) An ex-
ample of a typical experiment; (b) graph reporting the rate of swelling,
which is the slope in the dotted line in (a), in the absence (V), or in
the presence (v) of 2 g cyclosporine.
Fig. 5. Mitochondrial respiration and its inhibition by Sea-Ninet
([SN], Rohm & Haas, Philadelphia, PA, USA). The mitochondria (0.5
mg/ml) were resuspended in a medium containing: 0.25 M sucrose,
10 mM Hepes-Mops, 2 mM MgCl2, and 200 mM ethylene glycol-
bis(2-aminoethylether)-N,N,N9,N9-tetraacetic acid. The addition of the
substrate succinate (2 mM) induced a slow oxygen consumption (state
4 mitochondrial respiration). The addition of 100 nM/mg of the car-
bonyl cyanide 4-(trifluoro-methoxy)phenylhydrazone uncoupler stim-
ulated the respiratory rate up to a maximum value. In this condition,
the effects of the inhibitors of the respiratory chain (RC) can be
studied. Successive additions of SN induce a slowing of the RC up
to the point where a complete inhibition occurs. The graph (b) reports
the percentage of RC inhibition induced by the SN. The value of
100% corresponds to the respiratory rate in the presence of the car-
bonylcyanide-p-trifluoromethoxyphenyl hydrazone and in the absence
of SN.
A significant Ca21 efflux is observed only when the concen-
tration of SN is about 10 mM, thus demonstrating that SN
induces a membrane leak. This phenomenon, however, cannot
be the cause of the inhibition of ATP synthesis (Fig. 1) because
this inhibition occurs with lower doses of SN.
Opening of the permeability transition pore
In recent years [14], it has been demonstrated that many
chemical compounds induce the opening in mitochondria of
large-sized membrane pores (permeability transition pores)
that allow for the transport through the membrane of solutes
of about 1,500 Da (Dalton) in size. Consequently, the opening
of the permeability transition pore implies the inhibition of
ATP synthesis. The opening of the pore is inhibited by cyclo-
sporine and, as is due to a colloid-osmotic mechanism [14],
this is evidenced by the swelling of the mitochondria at 540
nm. Figure 4a shows a typical swelling experiment, induced
using SN, and the corresponding graph reports the swelling
rate at increasing doses of SN. The graph shows that the swell-
ing occurs when the dose of SN is about 10 mM. Because the
swelling is not cyclosporine-sensitive, the interpretation, in
this case, was that the swelling was due to a detergent effect
and not to the opening of a permeability transition pore. This
interpretation is suggested by the failure of the cyclosporine
sensitivity, but is supported by a comparison with the graph
in Figure 3b that shows a similar behavior. Therefore, we also
confirmed by means of these kinds of experiments (swelling
experiments) that SN induces a detergent effect, but that this
effect is not responsible for the ATP synthesis inhibition.
Inhibition of the RC
An inhibition of the RC causes an equivalent ATP-synthesis
inhibition. The possibility of an inhibition of the RC by SN
was evaluated by means of respiratory rate experiments (i.e.,
oxygen consumption experiments). Figure 5a shows a typical
experiment related to respiratory rate inhibition by SN using
succinate as substrate. The graph in Figure 5b reports the con-
sequent respiratory rate inhibition at increasing amounts of
SN. The graph shows that the dose necessary to induce an
inhibition of the respiratory chain is lower than that necessary
to induce a detergent effect. Therefore, this fact, together with
the comparison between the graph in Figure 5b and the graph
in Figure 1b, which reports the ATP synthesis inhibition, sug-
gests that the ATP synthesis inhibition (5toxicity) induced by
SN is due to an inhibition of the mitochondrial respiratory
chain.
Taking this conclusion into account, the RC was analyzed
further using different substrates for the mitochondrial RC:
Glutamate/malate, which allows for the functioning of the
whole RC and ascorbate/TMPD in order to analyze only the
third phosphorylating site. In both cases, we did not find any
inhibition of the RC. Therefore, we conclude that, as in the
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case of many toxic compounds, the preferential target of SN
in the mitochondria is the succinate deydrogenase [15].
An inhibition of the respiratory chain of mitochondria has
been observed with many toxic compounds; however, only in
some cases this interaction has been pointed out as the pre-
vailing effect obtained with the minimal doses of compounds.
The 2,29-3,39-2,29-4,49 and 2,29-5,59 tetrachloro biphenyls
(TCBs), as in the case of SN, are inhibitors of the succinate
dehydrogenase, and complex I and cytochrome oxidase were
unaffected [16]. Other authors [17] found that not only the
respiratory chain, but also the phosphorylation system is in-
hibited with 20 n mol TCB/mg protein, while the same dose
increases the membrane leak.
A similar behavior has been observed with DDE, the major
metabolite of DDT. The authors [18] find that the prevailing
effect (the effect with the lowest dose, 80 n mol/mg protein)
is the inhibition of the succinate dehydrogenase. At higher
doses, the compound uncouples the oxidative phosphorylation,
although the ATPase activity is unaffected.
In the case of DDT, the effect is controversial: An inhibition
of the respiratory chain with about 90 n mol/mg protein has
been observed in the ubiquinol-cytochrome c segment [19],
and Oyama et al. [20] and Byzkowsky and Tuczkiewicz [21]
found that the prevailing action is an uncoupling effect.
It is worth remarking, however, that many toxic compounds
of chemical and pharmacological interest inhibit complex II
in mitochondria [22–28]. These compounds are very different
in formula and structure and, because complex II is a very
complicated system [29], a structural explanation of the mech-
anism of inhibitory effects never has been proposed. For this
reason, even if a structure for complex II has been proposed
[29], in the case of SN we are not able to explain the mech-
anism of inhibition of SN on complex II.
A comparison with other antifouling compounds such as
trialkiltin compounds shows that the tributyltin (TBT), which
was the most extensively used, is much more toxic than SN
(the dosage of TBT necessary to inhibit ATP synthesis is about
1 n mol/mg [30], and the dose of SN necessary to counteract
the ATP synthesis is about 20 n mol/mg; Fig.1) and points to
different action mechanisms.
In the case of TBT and other trialkyltin and trialkyllead
compounds, the proposed mechanism is that the compounds
are Cl2/OH2 electroneutral exchangers in the mitochondrial
membrane [30,31].
More recently, a new model has been proposed [32,33] to
explain the toxicity in mitochondria and other membranes. The
authors propose that trialkyltin and trialkyllead compounds are
uncouplers of the oxidative phosphorylation. This is the con-
sequence of a cyclic mechanism in which the compounds enter
as trialkylSn1 (or trialkylPb1) and are extruded as trialkyl-
SnOH (or trialkylPbOH).
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